{"DataElement":{"publicId":"5914516","version":"1","preferredName":"Follicular Lymphoma FLIPI Overall Survival Score","preferredDefinition":"Number or range of numbers that represents the Follicular Lymphoma International Prognostic Index (FLIPI) score to predict overall survival.","longName":"FLIPI_OS_SCR","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"5914514","version":"1","preferredName":"Follicular Lymphoma Follicular Lymphoma International Prognostic Index Overall Survival","preferredDefinition":"A neoplasm of follicle centre B cells which has at least a partial follicular pattern.  Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide.  Most patients have widespread disease at diagnosis.  Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present.  The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)].  Histological grade correlates with prognosis.  Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001)._A prognostic index designed to be used for patients with follicular lymphoma to stratify them by risk. The index uses 5 parameters: age (≥ 60 years vs < 60 years), Ann Arbor stage (III-IV vs I-II), hemoglobin level (< 120 g/L vs ≥ 120 g/L), number of nodal areas involved (> 4 vs ≤ 4), serum LDH level (above normal vs normal or below) and divides patients into 3 risk groups: low (0-1 risk factors), intermediate (2 risk factors), high (≥ 3 risk factors)._A measure of the time until death from any cause.","longName":"2676495v1.0:5914512v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2676495","version":"1","preferredName":"Follicular Lymphoma","preferredDefinition":"A neoplasm of follicle centre B cells which has at least a partial follicular pattern.  Follicular lymphomas comprise about 35% of adult non-Hodgkin's lymphomas in the U.S. and 22% worldwide.  Most patients have widespread disease at diagnosis.  Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present.  The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)].  Histological grade correlates with prognosis.  Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001). -- 2003","longName":"C3209","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Follicular Lymphoma","conceptCode":"C3209","definition":"A neoplasm of follicle centre B cells which has at least a partial follicular pattern.  Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide.  Most patients have widespread disease at diagnosis.  Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present.  The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)].  Histological grade correlates with prognosis.  Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3939D50A-661F-43F5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-03","modifiedBy":"ONEDATA","dateModified":"2007-09-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5914512","version":"1","preferredName":"Follicular Lymphoma International Prognostic Index Overall Survival","preferredDefinition":"A prognostic index designed to be used for patients with follicular lymphoma to stratify them by risk. The index uses 5 parameters: age (≥ 60 years vs < 60 years), Ann Arbor stage (III-IV vs I-II), hemoglobin level (< 120 g/L vs ≥ 120 g/L), number of nodal areas involved (> 4 vs ≤ 4), serum LDH level (above normal vs normal or below) and divides patients into 3 risk groups: low (0-1 risk factors), intermediate (2 risk factors), high (≥ 3 risk factors).:A measure of the time until death from any cause.","longName":"C136962:C125201","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Follicular Lymphoma International Prognostic Index","conceptCode":"C136962","definition":"A prognostic index designed to be used for patients with follicular lymphoma to stratify them by risk. The index uses 5 parameters: age (greater than or equal to 60 years vs less than 60 years), Ann Arbor stage (III-IV vs I-II), hemoglobin level (less than 120 g/L vs greater than or equal to 120 g/L), number of nodal areas involved (greater than 4 vs less than or equal to 4), serum LDH level (above normal vs normal or below) and divides patients into 3 risk groups: low (0-1 risk factors), intermediate (2 risk factors), high (greater than or equal to 3 risk factors).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Overall Survival","conceptCode":"C125201","definition":"A measure of the time until death from any cause.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54C27117-22C5-44E6-E053-F662850A718A","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-20","modifiedBy":"ONEDATA","dateModified":"2017-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54C27117-22D6-44E6-E053-F662850A718A","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-20","modifiedBy":"COOPERM","dateModified":"2017-07-21","changeDescription":"Created for 17C0127 requested 7/13/17 by Y.Yakovlev. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5914149","version":"1","preferredName":"Follicular Lymphoma International Prognostic Index Score","preferredDefinition":"A prognostic index designed to be used for patients with follicular lymphoma to stratify them by risk. The index uses 5 parameters: age (≥ 60 years vs < 60 years), Ann Arbor stage (III-IV vs I-II), hemoglobin level (< 120 g/L vs ≥ 120 g/L), number of nodal areas involved (> 4 vs ≤ 4), serum LDH level (above normal vs normal or below) and divides patients into to 3 risk groups: low (0-1 risk factors), intermediate (2 risk factors), high (≥ 3 risk factors)._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"FLIPI_SCORE","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":">= 3","valueDescription":"High Risk","ValueMeaning":{"publicId":"5914150","version":"1","preferredName":"High Risk","longName":"5914150","preferredDefinition":"A score indicating that a patient has 3 or more risk factors associated with follicular lymphoma and is considered in the high risk group.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FLIPI Score Greater than or Equal to 3, High Risk","conceptCode":"C136968","definition":"A score indicating that a patient has 3 or more risk factors associated with follicular lymphoma and is considered in the high risk group.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54AE14E9-2F66-3CBE-E053-F662850A92E8","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5515D7BB-FA9D-46C7-E053-F662850A4D4E","beginDate":"2017-07-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-25","modifiedBy":"ONEDATA","dateModified":"2017-07-25","deletedIndicator":"No"},{"value":"0 to 1","valueDescription":"Low Risk","ValueMeaning":{"publicId":"5914152","version":"1","preferredName":"Low Risk","longName":"5914152","preferredDefinition":"A score indicating that a patient has 0 or 1 risk factors associated with follicular lymphoma and is considered in the low risk group.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FLIPI Score 0-1, Low Risk","conceptCode":"C136965","definition":"A score indicating that a patient has 0 or 1 risk factors associated with follicular lymphoma and is considered in the low risk group.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54AE14E9-2FB0-3CBE-E053-F662850A92E8","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54B2B673-20AA-56AE-E053-F662850A2B0C","beginDate":"2017-07-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-20","modifiedBy":"ONEDATA","dateModified":"2017-07-20","deletedIndicator":"No"},{"value":"2","valueDescription":"Intermediate Risk","ValueMeaning":{"publicId":"5914151","version":"1","preferredName":"Intermediate Risk","longName":"5914151","preferredDefinition":"A score indicating that a patient has 2 risk factors associated with follicular lymphoma and is considered in the intermediate risk group.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FLIPI Score 2, Intermediate Risk","conceptCode":"C136967","definition":"A score indicating that a patient has 2 risk factors associated with follicular lymphoma and is considered in the intermediate risk group.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54AE14E9-2F8B-3CBE-E053-F662850A92E8","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"54AE14E9-2FA4-3CBE-E053-F662850A92E8","beginDate":"2017-07-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-19","modifiedBy":"ONEDATA","dateModified":"2017-07-19","deletedIndicator":"No"},{"value":"3 to 5","valueDescription":"High Risk","ValueMeaning":{"publicId":"2762642","version":"1","preferredName":"High Risk","longName":"2762642","preferredDefinition":"The potential future harm that may arise from some present action or attribute or condition is almost certain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Risk","conceptCode":"C102401","definition":"The potential future harm that may arise from some present action or attribute or condition is almost certain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"510F69B8-A6A8-0143-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-07-02","modifiedBy":"HARTLEYG","dateModified":"2019-01-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D071FCAC-BA9D-5EDA-E053-4EBD850AE820","beginDate":"2021-11-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2021-11-10","modifiedBy":"ONEDATA","dateModified":"2021-11-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5914148","version":"1","preferredName":"Follicular Lymphoma International Prognostic Index Score","preferredDefinition":"A prognostic index designed to be used for patients with follicular lymphoma to stratify them by risk. The index uses 5 parameters: age (≥ 60 years vs < 60 years), Ann Arbor stage (III-IV vs I-II), hemoglobin level (< 120 g/L vs ≥ 120 g/L), number of nodal areas involved (> 4 vs ≤ 4), serum LDH level (above normal vs normal or below) and divides patients into 3 risk groups: low (0-1 risk factors), intermediate (2 risk factors), high (≥ 3 risk factors).:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C136962:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Follicular Lymphoma International Prognostic Index","conceptCode":"C136962","definition":"A prognostic index designed to be used for patients with follicular lymphoma to stratify them by risk. The index uses 5 parameters: age (greater than or equal to 60 years vs less than 60 years), Ann Arbor stage (III-IV vs I-II), hemoglobin level (less than 120 g/L vs greater than or equal to 120 g/L), number of nodal areas involved (greater than 4 vs less than or equal to 4), serum LDH level (above normal vs normal or below) and divides patients into 3 risk groups: low (0-1 risk factors), intermediate (2 risk factors), high (greater than or equal to 3 risk factors).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54AE14E9-2F3D-3CBE-E053-F662850A92E8","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-19","modifiedBy":"ONEDATA","dateModified":"2017-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"54AE14E9-2F4E-3CBE-E053-F662850A92E8","latestVersionIndicator":"Yes","beginDate":"2017-07-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-19","modifiedBy":"HARTLEYG","dateModified":"2021-11-10","changeDescription":"Created for 16c0171 requested 7/17/17 by Y.Yakovlev. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"FLIPI Score","type":"Preferred Question Text","description":"FLIPI Score","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"54C46327-A8BD-231D-E053-F662850A0E46","latestVersionIndicator":"Yes","beginDate":"2017-07-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-07-20","modifiedBy":"COOPERM","dateModified":"2017-07-21","changeDescription":"Created for 17C0127 requested by Y.Yakovlev 7/13/17. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}